| Title : Role of Evogliptin for Intra-Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi-Center, Prospective, Observational Study (REVISE Study) - Lee_2026_Endocrinol.Diabetes.Metab_9_e70270 |
| Author(s) : Lee JE , Hong JH , Yu SH , Baek KH , Yu J , Lee SJ , Kim HW , Park KS , Kim JH , Min K , Lee YH , Kim KS , Song MS , Won JC |
| Ref : Endocrinol Diabetes Metab , 9 :e70270 , 2026 |
| Abstract : |
| PubMedSearch : Lee_2026_Endocrinol.Diabetes.Metab_9_e70270 |
| PubMedID: 42383539 |
| Title : Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational Study - Hong_2026_Diabetes.Obes.Metab__ |
| Author(s) : Hong JH , Yu SH , Baek KH , Yu J , Lee SJ , Kim HW , Park KS , Kim JH , Min K , Lee YH , Kim KS , Song MS , Lee JE , Won JC |
| Ref : Diabetes Obes Metab , : , 2026 |
| Abstract : |
| PubMedSearch : Hong_2026_Diabetes.Obes.Metab__ |
| PubMedID: 41749418 |
| Title : Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db\/db mice - Pham_2023_Exp.Mol.Med__ |
| Author(s) : Pham TK , Nguyen THT , Yi JM , Kim GS , Yun HR , Kim HK , Won JC |
| Ref : Exp Mol Med , : , 2023 |
| Abstract : |
| PubMedSearch : Pham_2023_Exp.Mol.Med__ |
| PubMedID: 37009790 |